51˶

Endocrinologist Deserts; U.S. Obesity Declines; New Obesity Definition Coming Soon

— News and commentary from the endocrinology world

MedpageToday
Endo Break over a computer rendering of a man with illustrated body organs.

Almost 70% of U.S. counties are "endocrinologist deserts," meaning , according to GoodRx.

In a phase IV trial of patients with Cushing's syndrome and a baseline HbA1c over 7.5%, those who received mifepristone (Korlym) had a than placebo by week 24, Corcept Therapeutics said.

Americans' average body mass index and , the first drop in more than a decade, cross-sectional data suggested. (JAMA Health Forum)

In the 15-week phase III THRIVE-2 trial, investigational veligrotug significantly in people with chronic thyroid eye disease, said Viridian Therapeutics.

The Lancet Diabetes & Endocrinology Commission on Diagnostic Criteria of Clinical Obesity will soon unveil a that's endorsed by 75 medical organizations.

Cheaper vials of tirzepatide (Zepbound) will be Ro through a partnership with Eli Lilly. (CNBC)

The American Diabetes Association released its ; updates include recommendations for continuous glucose monitors and caution about compounded GLP-1 drugs. (Diabetes Care)

Early life polychlorinated biphenyls was linked to some neurobehavioral problems in a rat model. (Journal of the Endocrine Society)

A lawsuit accused major food companies of by designing ultraprocessed foods to be addictive to children. (CNN)

Dexcom said its prescription-free glucose biosensor Stelo now has an to help improve metabolic health.

Some people are (Ozempic, Wegovy) and other weight-loss medications. Does it work? (New York Times)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.